In one of the first district court opinions applying the Federal Circuit’s recent GSK decision on induced infringement in the context of label carve-outs, Judge Richard Andrews in the.
Delaware held that plaintiff Amarin Pharma failed to plead facts sufficient to show that Hikma Pharmaceuticals’ carved-out product label and/or public marketing statements induced infringement of Amarin’s patents.
Delaware held that plaintiff Amarin Pharma failed to plead facts sufficient to show that Hikma Pharmaceuticals’ carved-out product label and/or public marketing statements induced infringement of Amarin’s patents.
Delaware Magistrate Judge: Novel Induced-Infringement Claim Against Health Insurance Provider Survives Dismissal - Intellectual Property mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.